These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32736255)
1. An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition. Wang K; Ye H; Zhang X; Wang X; Yang B; Luo C; Zhao Z; Zhao J; Lu Q; Zhang H; Kan Q; Wang Y; He Z; Sun J Biomaterials; 2020 Oct; 257():120224. PubMed ID: 32736255 [TBL] [Abstract][Full Text] [Related]
2. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer. Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911 [TBL] [Abstract][Full Text] [Related]
3. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells. Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904 [TBL] [Abstract][Full Text] [Related]
4. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition. Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626 [TBL] [Abstract][Full Text] [Related]
5. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer. Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661 [TBL] [Abstract][Full Text] [Related]
7. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles. Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335 [TBL] [Abstract][Full Text] [Related]
8. Dual pH/ROS-Responsive Nanoplatform with Deep Tumor Penetration and Self-Amplified Drug Release for Enhancing Tumor Chemotherapeutic Efficacy. Li Y; Chen M; Yao B; Lu X; Song B; Vasilatos SN; Zhang X; Ren X; Yao C; Bian W; Sun L Small; 2020 Aug; 16(32):e2002188. PubMed ID: 32627387 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy. Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764 [TBL] [Abstract][Full Text] [Related]
10. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis. Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504 [TBL] [Abstract][Full Text] [Related]
11. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer. Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222 [TBL] [Abstract][Full Text] [Related]
12. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy. Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370 [TBL] [Abstract][Full Text] [Related]
13. Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer. Pang L; Zhang L; Zhou H; Cao L; Shao Y; Li T Front Chem; 2022; 10():844426. PubMed ID: 35308794 [TBL] [Abstract][Full Text] [Related]
14. Polydopamine-modified ROS-responsive prodrug nanoplatform with enhanced stability for precise treatment of breast cancer. Yang B; Wang K; Zhang D; Ji B; Zhao D; Wang X; Zhang H; Kan Q; He Z; Sun J RSC Adv; 2019 Mar; 9(16):9260-9269. PubMed ID: 35517686 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390 [TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy. Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088 [TBL] [Abstract][Full Text] [Related]
17. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer. Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051 [TBL] [Abstract][Full Text] [Related]
18. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model. Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551 [TBL] [Abstract][Full Text] [Related]
19. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504 [TBL] [Abstract][Full Text] [Related]
20. Enzyme-Sensitive and Amphiphilic PEGylated Dendrimer-Paclitaxel Prodrug-Based Nanoparticles for Enhanced Stability and Anticancer Efficacy. Li N; Cai H; Jiang L; Hu J; Bains A; Hu J; Gong Q; Luo K; Gu Z ACS Appl Mater Interfaces; 2017 Mar; 9(8):6865-6877. PubMed ID: 28112512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]